362 related articles for article (PubMed ID: 18241925)
1. Improving the refolding of NTA protein by urea gradient and arginine gradient size-exclusion chromatography.
Fan X; Xu D; Lu B; Xia J; Wei D
J Biochem Biophys Methods; 2008 Apr; 70(6):1130-8. PubMed ID: 18241925
[TBL] [Abstract][Full Text] [Related]
2. Refolding and purification of rhNTA protein by chromatography.
Fan X; Xu D; Lu B; Xia J; Wei D
Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
[TBL] [Abstract][Full Text] [Related]
3. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
Wang C; Wang L; Geng X
Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
[TBL] [Abstract][Full Text] [Related]
4. Lysozyme refolding at high concentration by dilution and size-exclusion chromatography.
Goa YG; Guan YX; Yao SJ; Cho MG
J Zhejiang Univ Sci; 2003; 4(2):136-41. PubMed ID: 12659225
[TBL] [Abstract][Full Text] [Related]
5. Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies.
Gu Z; Weidenhaupt M; Ivanova N; Pavlov M; Xu B; Su ZG; Janson JC
Protein Expr Purif; 2002 Jun; 25(1):174-9. PubMed ID: 12071713
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression, and refolding of a secretory protein ESAT-6 of Mycobacterium tuberculosis.
Wang BL; Xu Y; Wu CQ; Xu YM; Wang HH
Protein Expr Purif; 2005 Feb; 39(2):184-8. PubMed ID: 15642469
[TBL] [Abstract][Full Text] [Related]
7. Effect of sample loop dimension on lysozyme refolding in size-exclusion chromatography.
Wang SS; Chang CK; Liu HS
J Chromatogr A; 2007 Aug; 1161(1-2):56-63. PubMed ID: 17448483
[TBL] [Abstract][Full Text] [Related]
8. Refolding of a staphylokinase variant y1-Sak by reverse dilution.
He J; Wang G; Xu R; Feng J; Wang J; Su H; Song H
Appl Biochem Biotechnol; 2008 Oct; 151(1):29-41. PubMed ID: 18785020
[TBL] [Abstract][Full Text] [Related]
9. Refolding of recombinant human interferon alpha-2a from Escherichia coli by urea gradient size exclusion chromatography.
Gao F; Shi L; Xu LX
Prikl Biokhim Mikrobiol; 2013; 49(1):17-23. PubMed ID: 23662445
[TBL] [Abstract][Full Text] [Related]
10. A comparative investigation on different refolding strategies of recombinant human tissue-type plasminogen activator derivative.
Liu H; Zhou X; Zhang Y
Biotechnol Lett; 2006 Apr; 28(7):457-63. PubMed ID: 16614926
[TBL] [Abstract][Full Text] [Related]
11. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
Tran-Moseman A; Schauer N; De Bernardez Clark E
Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the expression, purification and renaturation of recombinant N-acety-L-ornithine deacetylase].
Li H; Chen Y; Weng QP; Wu MG; Wei P; Ouyang PK
Sheng Wu Gong Cheng Xue Bao; 2007 May; 23(3):487-92. PubMed ID: 17577999
[TBL] [Abstract][Full Text] [Related]
13. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
[TBL] [Abstract][Full Text] [Related]
14. Urea gradient size-exclusion chromatography enhanced the yield of lysozyme refolding.
Gu Z; Su Z; Janson JC
J Chromatogr A; 2001 May; 918(2):311-8. PubMed ID: 11407577
[TBL] [Abstract][Full Text] [Related]
15. On-column refolding of corticotropin-releasing factor receptor 1 extracellular domain by size exclusion chromatography.
Ersoy M; Matic S; Schmidt SR
Biomed Chromatogr; 2009 Oct; 23(10):1121-8. PubMed ID: 19404927
[TBL] [Abstract][Full Text] [Related]
16. Refolding of partially and fully denatured lysozymes.
Lin JL; Ruaan RC; Hsieh HJ
Biotechnol Lett; 2007 May; 29(5):723-9. PubMed ID: 17310324
[TBL] [Abstract][Full Text] [Related]
17. Effect of additives on refolding of a denatured protein.
Yasuda M; Murakami Y; Sowa A; Ogino H; Ishikawa H
Biotechnol Prog; 1998; 14(4):601-6. PubMed ID: 9694682
[TBL] [Abstract][Full Text] [Related]
18. Expression, refolding, and activity of a recombinant nonhemorrhagic snake venom metalloprotease.
Selistre-de-Araujo HS; de Souza EL; Beltramini LM; Ownby CL; Souza DH
Protein Expr Purif; 2000 Jun; 19(1):41-7. PubMed ID: 10833388
[TBL] [Abstract][Full Text] [Related]
19. Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation.
Suenaga M; Ohmae H; Tsuji S; Itoh T; Nishimura O
Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():119-24. PubMed ID: 9756741
[TBL] [Abstract][Full Text] [Related]
20. In vitro refolding with simultaneous purification of recombinant human parathyroid hormone (rhPTH 1-34) from Escherichia coli directed by protein folding size exclusion chromatography (PF-SEC): implication of solution additives and their role on aggregates and renaturation.
Vemula S; Vemula S; Dedaniya A; Ronda SR
Anal Bioanal Chem; 2016 Jan; 408(1):217-29. PubMed ID: 26472319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
